These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2006-004937-13||multicentee randomized controlled study of azathioprine versus iterferon beta in relapsing remitting multiple sclerosis||not-yet-due|
|Ongoing||2008-005028-10||Methadone dose adjustments, plasma R-methadone levels and therapeutic outcome of opioid addiction||not-yet-due|
|Ongoing||2010-022835-13||The Effects of Nicotine withdrawal on Panic-like Response to Breath Holding: A Placebo-Controlled, Double-Blind, Cross-Over Patch Study||not-yet-due|
|Ongoing||2012-002253-30||A phase 2 study of Ruxolitinib in patients with splanchnic vein thrombosis associated with myeloproliferative neoplasm Studio di fase II del Ruxolitinib in pazienti con Trombosi delle Vene Splancni...||not-yet-due|
|Ongoing||2013-001890-26||Recombinant human parathyroid hormone [rh PTH(1-34): Teriparatide] as therapy for refractory hypoparathyroidism Ormone paratiroideo ricombinante umano [rh PTH(1-34): Teriparatide] per il trattament...||not-yet-due|
|Ongoing||2014-004134-26||A MULTICENTER, PROSPECTIVE, SINGLE ARM, OPEN-LABEL, PILOT STUDY ON THE BENEFIT/COST/SAFETY PROFILE OF SOFOSBUVIR FOR SYMPTOMATIC MIXED CRYOGLOBULINEMIA Studio pilota multicentrico, prospettico, a s...||not-yet-due|
|Ongoing||2014-004422-17||Double-blinded placebo-controlled study on men with lower urinary tract symptoms secondary to prostatic hyperplasia (LUTS-BPH) to assess changes in pressure flow study (PFS) and in molecular profile o...||not-yet-due|
|Ongoing||2015-000914-23||Cardiac toxicity prevention in non-metastatic breast cancer patients treated with anthracycline-based chemotherapy: a randomized, placebo controlled, phase 3 trial - SAFE trial. MONITORAGGIO E PREV...||not-yet-due|
|Ongoing||2016-005284-13||A 2 arm, phase II controlled randomized trial comparing efficacy and safety of abiraterone and abiraterone associated with Ablative Radiation Therapy in patients with Oligometastatic castration resist...||not-yet-due|
|Ongoing||2020-000428-21||ExclUsive endocRine therapy Or Partial breast irradiation for women aged =70 years with luminal A-like early stage breast cancer (EUROPA): a randomized phase 3 non-inferiority trial. Terapia endocr...||not-yet-due|
|Ongoing||2020-001165-36||A Phase 2, Monocentric, Pilot Study to evaluate safety and efficacy of CC 486 (Oral Azacitidine) Plus Best Supportive Care as maintenance of response to sc azacitidine in IPSS higher risk elderly MDS ...||not-yet-due|